NO850007L - Antibiotisk forbindelse og fremgangsmaate til fremstilling av forbindelsen og blandinger inneholdende forbindelsen - Google Patents

Antibiotisk forbindelse og fremgangsmaate til fremstilling av forbindelsen og blandinger inneholdende forbindelsen

Info

Publication number
NO850007L
NO850007L NO850007A NO850007A NO850007L NO 850007 L NO850007 L NO 850007L NO 850007 A NO850007 A NO 850007A NO 850007 A NO850007 A NO 850007A NO 850007 L NO850007 L NO 850007L
Authority
NO
Norway
Prior art keywords
compound
preparing
procedure
mixtures containing
antibiotic
Prior art date
Application number
NO850007A
Other languages
English (en)
Other versions
NO160263B (no
NO160263C (no
Inventor
Martti Lauri Marvola
Esko Veikko Marttila
Jaakko Antero Uotila
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Erkki Juhani Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of NO850007L publication Critical patent/NO850007L/no
Publication of NO160263B publication Critical patent/NO160263B/no
Publication of NO160263C publication Critical patent/NO160263C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
NO850007A 1984-01-06 1985-01-02 Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat. NO160263C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (3)

Publication Number Publication Date
NO850007L true NO850007L (no) 1985-07-08
NO160263B NO160263B (no) 1988-12-19
NO160263C NO160263C (no) 1989-03-29

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850007A NO160263C (no) 1984-01-06 1985-01-02 Analogifremgangsmaate til fremstilling av antibiotisk acetylerytromycistearat.

Country Status (38)

Country Link
US (1) US4599326A (no)
JP (1) JPS60158197A (no)
KR (1) KR900006237B1 (no)
AT (1) AT386414B (no)
AU (1) AU565688B2 (no)
BE (1) BE901411A (no)
BG (1) BG43189A3 (no)
CA (1) CA1224461A (no)
CH (1) CH666275A5 (no)
CS (1) CS247191B2 (no)
CY (1) CY1462A (no)
DE (1) DE3500179A1 (no)
DK (1) DK149776C (no)
ES (1) ES8605818A1 (no)
FI (1) FI77249C (no)
FR (1) FR2557878B1 (no)
GB (1) GB2152502B (no)
HK (1) HK11590A (no)
HU (1) HU196221B (no)
IE (1) IE57967B1 (no)
IL (1) IL73885A (no)
IS (1) IS2968A7 (no)
IT (1) IT1184304B (no)
KE (1) KE3841A (no)
LU (1) LU85721A1 (no)
MA (1) MA20316A1 (no)
MX (1) MX156277A (no)
NL (1) NL8403979A (no)
NO (1) NO160263C (no)
NZ (1) NZ210606A (no)
PH (1) PH22471A (no)
PL (1) PL144349B1 (no)
PT (1) PT79777B (no)
RO (1) RO91262B (no)
SE (1) SE461854B (no)
SU (1) SU1410866A3 (no)
YU (1) YU44485B (no)
ZA (1) ZA8410143B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US7771707B2 (en) 2004-06-12 2010-08-10 Collegium Pharmaceutical, Inc. Abuse-deterrent drug formulations
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル， インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
AU2004285531A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption of metformin
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (en) 2004-08-25 2006-03-09 The Uab Research Foundation Absorption enhancers for drug administration
CA2743725A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Llc Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
WO2012158964A2 (en) 2011-05-18 2012-11-22 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals for osteoporosis
EP2922877B1 (en) 2012-11-20 2018-09-05 Eumederis Pharmaceuticals, Inc. Improved peptide pharmaceuticals
JP6525456B2 (ja) 2012-11-20 2019-06-05 メデリス ダイアビーティーズ，エルエルシー インスリン抵抗性のための改善されたペプチド製剤
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
DK3155017T3 (da) 2014-05-28 2024-04-15 Mederis Diabetes Llc Forbedrede lægemidler til insulinresistens
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
WO2018213751A1 (en) 2017-05-19 2018-11-22 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
HRP20221525T1 (hr) 2018-02-06 2023-03-03 Aegis Therapeutics, Llc Intranazalne formulacije epinefrina i postupci za liječenje bolesti
WO2020131704A1 (en) * 2018-12-17 2020-06-25 Lunella Biotech, Inc. Triple combination therapies for anti-aging
PE20211551A1 (es) * 2018-12-17 2021-08-16 Lunella Biotech Inc Terapias de combinacion triple para fijar como objetivo mitocondrias y aniquilar celulas madre cancerosas
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2557878A1 (fr) 1985-07-12
ES539349A0 (es) 1986-04-01
DE3500179C2 (no) 1989-08-24
FI850023A0 (fi) 1985-01-03
SE461854B (sv) 1990-04-02
GB2152502B (en) 1987-10-07
SE8406671D0 (sv) 1984-12-28
PL251457A1 (en) 1985-11-05
JPH029040B2 (no) 1990-02-28
BE901411A (fr) 1985-04-16
NO160263B (no) 1988-12-19
CH666275A5 (de) 1988-07-15
IT1184304B (it) 1987-10-28
CS247191B2 (en) 1986-12-18
KE3841A (en) 1989-04-07
GB2152502A (en) 1985-08-07
FI77249B (fi) 1988-10-31
CA1224461A (en) 1987-07-21
PH22471A (en) 1988-09-12
KR850005452A (ko) 1985-08-26
AT386414B (de) 1988-08-25
SU1410866A3 (ru) 1988-07-15
IE57967B1 (en) 1993-06-02
ZA8410143B (en) 1985-08-28
PL144349B1 (en) 1988-05-31
MA20316A1 (fr) 1985-10-01
IS2968A7 (is) 1985-04-03
DK5884A (da) 1985-07-07
RO91262B (ro) 1987-07-01
SE8406671L (sv) 1985-07-07
BG43189A3 (en) 1988-04-15
AU3705984A (en) 1985-07-11
KR900006237B1 (ko) 1990-08-27
RO91262A (ro) 1987-06-30
DK5884D0 (da) 1984-01-06
LU85721A1 (fr) 1985-07-24
YU44485B (en) 1990-08-31
DK149776C (da) 1987-04-21
ATA985A (de) 1988-01-15
GB8432368D0 (en) 1985-02-06
FR2557878B1 (fr) 1988-01-15
IL73885A (en) 1988-10-31
JPS60158197A (ja) 1985-08-19
IE850022L (en) 1985-07-06
US4599326A (en) 1986-07-08
DE3500179A1 (de) 1985-07-18
HU196221B (en) 1988-10-28
YU2085A (en) 1987-12-31
PT79777B (en) 1986-10-21
HK11590A (en) 1990-02-23
NZ210606A (en) 1987-08-31
AU565688B2 (en) 1987-09-24
FI77249C (fi) 1989-02-10
DK149776B (da) 1986-09-29
PT79777A (en) 1985-01-01
ES8605818A1 (es) 1986-04-01
IL73885A0 (en) 1985-03-31
NL8403979A (nl) 1985-08-01
NO160263C (no) 1989-03-29
FI850023L (fi) 1985-07-07
CY1462A (en) 1989-07-21
MX156277A (es) 1988-08-04
IT8519012A0 (it) 1985-01-04
HUT37628A (en) 1986-01-23

Similar Documents

Publication Publication Date Title
NO850007L (no) Antibiotisk forbindelse og fremgangsmaate til fremstilling av forbindelsen og blandinger inneholdende forbindelsen
DK313086A (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
DK437286A (da) 2,5-diaryl-tetrahydrothiophenforbindelse og fremgangsmaade til fremstilling deraf
DK51286A (da) Desoxyadenosinphosphatforbindelser og fremgangsmaade til fremstilling afdisse
NO163402C (no) Fremgangsmaate for fremstilling av acylerte diketonforbindelser.
GB8720552D0 (en) Four point seal
DK330187D0 (da) Chromoforholdig solfilterforbindelse og sammensaetning indeholdende samme
NO853120L (no) Isfjell og fremgangsmaate for fremstilling av samme.
DK474585A (da) Fremgangsmaade til mikroindkapsling
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK166485D0 (da) Antibiotiske og antitumoraktive forbindelser cl-1724, praeparater indeholdende disse samt fremgangsmaade til fremstilling deraf
DK52986A (da) Fremgangsmaade til fremstilling af antibiotikum l 17392 (deglucoteicoplanin)
DE3465148D1 (en) Lock-in amplifiers
DK584484D0 (da) Kemisk fremgangsmaade til fremstilling af antibiotikum l 17054
DK52885D0 (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK129983A (da) 2-beta-d-ribofuranosylselenazol-4-carboxamidforbindelser og fremgangsmaader til fremstilling deraf
GB8714750D0 (en) Demagnetizer
DK446685A (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
DK357685A (da) Fremgangsmaade til makrolid alkylering
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK230286D0 (da) Phosphinguldforbindelser og fremgangsmaade til fremstilling deraf
DK47184D0 (da) Benzazepin-derivater og fremgangsmaade til fremstilling deraf
NO170761C (no) Askorbat-2-polyfosfatforbindelser og fremgangsmaate til fremstilling derav
NO170276C (no) 3-hydroxypyrazolforbindelser og fremgangsmaate for fremstilling av slike